Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

5,6-MeO-MiPT

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
5,6-MeO-MiPT
Clinical data
Other names5,6-Dimethoxy-N-methyl-N-isopropyltryptamine
Routes of
administration
Oral[1]
Drug classSerotonin receptor modulator
ATC code
  • None
Pharmacokinetic data
Onset of actionUnknown[1]
Duration of actionUnknown[1]
Identifiers
  • N-[2-(5,6-dimethoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC16H24N2O2
Molar mass276.380 g·mol−1
3D model (JSmol)
  • CC(C)N(C)CCc2c[nH]c1cc(OC)c(OC)cc12
  • InChI=1S/C16H24N2O2/c1-11(2)18(3)7-6-12-10-17-14-9-16(20-5)15(19-4)8-13(12)14/h8-11,17H,6-7H2,1-5H3
  • Key:XXWWFLAMFUOAQG-UHFFFAOYSA-N

5,6-MeO-MiPT, also known as5,6-dimethoxy-N-methyl-N-isopropyltryptamine, is achemical compound of thetryptamine family.[1] It is the 5,6-dimethoxyderivative ofmethylisopropyltryptamine (MiPT) and is ananalogue of5-MeO-MiPT.[1] In his 1991 bookTiHKAL (Tryptamines I Have Known and Loved),Alexander Shulgin listed the dose as greater than 75 mgorally and theduration as unknown.[1] The drug produced few to no effects at doses of up to 75 mg orally.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 5,6-MeO-MiPT.[1] However, the drug has been found to have abolished or profoundly reducedaffinities forserotonin receptors compared topsychedelic tryptamines like MiPT and 5-MeO-MiPT.[2] Itschemical synthesis has been described.[1] 5,6-MeO-MiPT was first described in thescientific literature byDavid Repke and Alexander Shulgin and colleagues.[3]

See also

[edit]

References

[edit]
  1. ^abcdefghiShulgin, Alexander;Shulgin, Ann (September 1997).TiHKAL: The Continuation.Berkeley, California:Transform Press.ISBN 0-9630096-9-9.OCLC 38503252.
  2. ^McKenna DJ, Repke DB, Lo L, Peroutka SJ (March 1990). "Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes".Neuropharmacology.29 (3):193–198.doi:10.1016/0028-3908(90)90001-8.PMID 2139186.
  3. ^Repke DB, Grotjahn DB, Shulgin AT (July 1985). "Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents".J Med Chem.28 (7):892–896.doi:10.1021/jm00145a007.PMID 4009612.

External links

[edit]
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Stub icon

Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=5,6-MeO-MiPT&oldid=1323800879"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp